Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Roberts' Agrylin receives orphan drug status in Japan

June 10, 1999

Elevated troponin T levels predict beneficial response to abciximab in unstable angina

June 8, 1999

Potent, orally active antiplatelet fibrinogen antagonists in early development at Ortho-McNeil

June 8, 1999

Chiron begins first clinical trial of in vivo gene therapy for hemophilia

June 4, 1999

PGI2 agonists under study at Fujisawa

June 2, 1999

Orally active anticoagulants described by Daiichi

June 2, 1999

New perspectives for rFVIIa and rFVIIai

June 1, 1999

Fragmin approved in U.S. for treatment of unstable angina and non-Q wave MI

May 31, 1999

Avigen cleared to begin human trials of gene therapy product for hemophilia

May 26, 1999

Thrombin inhibitors developed by Merck scientists

May 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.